NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a growth hormone drug shrink fatty liver? new trial aims to find out
Disease control Recruiting nowThis study tests whether a daily injection of tesamorelin can safely reduce liver fat in adults with metabolic fatty liver disease (MASLD). About 120 participants will receive either the drug or a placebo for 52 weeks, along with lifestyle advice. The main goal is to measure chan…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Could a low dose thyroid hormone help veterans with fatty liver disease?
Disease control Recruiting nowThis study tests whether a low dose of thyroid hormone (Synthroid) can help Veterans with NASH, a serious liver condition that can lead to liver failure or cancer. About 128 overweight or obese Veterans with NASH will receive either the hormone or a placebo daily for 52 weeks. Th…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
HIV drug showdown: which is safer for your liver?
Knowledge-focused Recruiting nowThis study aims to find out if two types of HIV medications (NNRTI and INSTI) cause different levels of fatty liver disease in people with HIV. Researchers will screen 200 HIV patients using ultrasound to measure liver fat and stiffness. The goal is to learn which drug class may …
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC
-
New study aims to catch liver failure early in NASH patients
Knowledge-focused Recruiting nowThis study follows 240 adults with NASH-related cirrhosis to find better ways to detect early signs of liver decompensation, such as internal bleeding, fluid buildup, or confusion. Researchers will track deaths and complications over time using routine exams and tests. The goal i…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC